title: TAVR and Thrombosis.
authors.forename: George
authors.initials: G
authors.lastname: Trantalis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Toutouzas
authors.forename: George
authors.initials: G
authors.lastname: Latsios
authors.forename: Andreas
authors.initials: A
authors.lastname: Synetos
authors.forename: Styliani
authors.initials: S
authors.lastname: Brili
authors.forename: Dimitra
authors.initials: D
authors.lastname: Logitsi
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Penesopoulou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Tousoulis
mesh_terms: D000368:Aged; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006350:Heart Valve Prosthesis; D006801:Humans; D011475:Prosthesis Failure; D012720:Severity of Illness Index; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D014057:Tomography, X-Ray Computed; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects* / Q000295:instrumentation; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents